New ACC/AHA guidelines provide updated recommendations for dyslipidemia management, focusing on atherogenic lipoproteins and ...
Findings come as ACC/AHA guidelines recognize polygenic risk as an ASCVD risk enhancer MENLO PARK, Calif., March 20, 2026 /PRNewswire/ -- MyOme, a leader in clinical whole-genome analysis and ...
The ACC and AHA released updated guidelines for the management of dyslipidemia to reduce risk for atherosclerotic ...
In a clinical practice guideline issued by the American College of Cardiology, the American Heart Association, and nine other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results